Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) with Unani Drug
Phase 2
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2023/01/049245
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of both gender
2.Age group of 20 â?? 60 years
3.Non-Alcoholic Fatty liver Grade I (Mild) and II (Moderate) based on Ultrasonography
4.Mildly raised liver enzymes (SGPTup to 100 IU/L and SGOT up to 80 IU/L)
Exclusion Criteria
1.Pregnancy and lactation
2.Fatty liver â?? Grade III(severe) and above, focal fatty liver cases and cirrhosis
3.Known cases of Hepatitis and other liver diseases
4.History of metabolic disorders like diabetes mellitus
5.History of alcoholism
6.Hypothyroidism
7.Cholelithiasis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method